Changing the anti-tumor immune response through differentially glycosylated tumor-specific IgG

Project: DFG ProjectsDFG Scholarships: Research Fellowships

Search results

  • 2019

    Targeting the CBM complex causes Treg cells to prime tumours for immune checkpoint therapy

    Di Pilato, M., Kim, E. Y., Cadilha, B. L., Prüßmann, J. N., Nasrallah, M. N., Seruggia, D., Usmani, S. M., Misale, S., Zappulli, V., Carrizosa, E., Mani, V., Ligorio, M., Warner, R. D., Medoff, B. D., Marangoni, F., Villani, A. C. & Mempel, T. R., 06.06.2019, In: Nature. 570, 7759, p. 112-116 5 p.

    Research output: Journal ArticlesJournal articlesResearchpeer-review

    133 Citations (Scopus)